Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 258 are a BUY (85.71%), 43 are a HOLD (14.29%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 30.25% that have a potential upside of 54.05% achieved within 94 days.
Emily Bodnar’s has documented 514 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VTVT, vTv Therapeutics at 19-Dec-2025.
Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 21-Jun-2023
$48
$0.45 (0.95%)
$48
2 years 4 months 30 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
Since 26-Jun-2023
$56
2 years 6 months 13 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
Since 20-Jun-2023
$48
$0.45 (0.95%)
$68
2 years 6 months 19 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
Since 24-May-2023
$48
$0.45 (0.95%)
$38
2 years 6 months 19 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
Since 20-Jun-2023
$48
$0.45 (0.95%)
$71
2 years 6 months 19 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?